Company
Virbac SA
Headquarters: Carros, France
Employees: 4,907
CEO: Mr. Habib Ramdani
Market Cap
€2.42 Billion
EUR as of July 1, 2023
US$2.64 Billion
France
Top Competitors by Market Capitalization
Industry: Drug Manufacturers—General
| Company | Market Cap (USD) |
|---|---|
Lilly
|
$417.05 B |
|
Johnson & Johnson
|
$412.24 B |
|
Merck
|
$275.82 B |
Roche
|
$241.08 B |
|
AbbVie
|
$239.18 B |
Sector:
| Company | Market Cap (USD) |
|---|---|
|
UnitedHealth Group
|
$428.70 B |
|
Lilly
|
$417.05 B |
|
Johnson & Johnson
|
$412.24 B |
Novo Nordisk
|
$329.83 B |
|
Merck
|
$275.82 B |
Detailed Description
Virbac SA manufactures and sells pharmaceutical, biological, nutritional, and diagnostic products for companion and food-producing animals in France, Europe, Latin America, North America, the Asia Pacific, and the Middle East and Africa. The company offers a range of vaccines, dental hygiene, reproduction, dermatology, parasiticides, diagnostic, antibiotics, and aquaculture products; and veterinary medicines for anesthesia, geriatrics, behavior, and injectable micronutrients, as well as petfood and electronic identification. Virbac SA was founded in 1968 and is headquartered in Carros, France.
Unlock the Power of Financial AI:
Try Disfold AI Free for 7 Days!
Stocks & Indices
Virbac SA has the following listings and related stock indices.
Stock: Euronext: VIRP wb_incandescent
Stock: FSX: V16 wb_incandescent
Stock: OTC: VRBCF wb_incandescent